BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14739595)

  • 1. Induction of apoptosis by tumor cell-targeted toxins.
    Thorburn A; Thorburn J; Frankel AE
    Apoptosis; 2004 Jan; 9(1):19-25. PubMed ID: 14739595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric fusion proteins--diphtheria toxin-based.
    Frankel AE; Powell BL; Vallera DA; Neville DM
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1294-301. PubMed ID: 11717818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer with phosphodiesterase inhibitors.
    Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
    Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted toxins.
    Frankel AE; Kreitman RJ; Sausville EA
    Clin Cancer Res; 2000 Feb; 6(2):326-34. PubMed ID: 10690507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-toxin conjugates: a new approach to cancer therapy.
    McIntosh DP
    Adv Biotechnol Processes; 1984; 3():111-39. PubMed ID: 6399840
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in cancer therapy targeting c-Met signaling pathway.
    Jung KH; Park BH; Hong SS
    Arch Pharm Res; 2012 Mar; 35(4):595-604. PubMed ID: 22553051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic apoptosis-inducing proteins exhibited anticancer activity in vitro and in vivo.
    Yu CL; Tsai MH
    Anticancer Res; 2001; 21(3B):1839-56. PubMed ID: 11497268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric fusion proteins--Pseudomonas exotoxin-based.
    Kreitman RJ
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1282-93. PubMed ID: 11717817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.
    Bremer E; Helfrich W
    Discov Med; 2006 Jun; 6(33):113-7. PubMed ID: 17234145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL receptor signaling and therapeutics.
    Abdulghani J; El-Deiry WS
    Expert Opin Ther Targets; 2010 Oct; 14(10):1091-108. PubMed ID: 20819019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells.
    Shulga-Morskoy S; Rich BE
    Protein Eng Des Sel; 2005 Jan; 18(1):25-31. PubMed ID: 15790577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.
    Shilova O; Shramova E; Proshkina G; Deyev S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis modulators as cancer therapeutics.
    Penn LZ
    Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
    Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
    Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARTS-based anticancer therapy: taking aim at cancer stem cells.
    Elhasid R; Larisch S
    Future Oncol; 2011 Oct; 7(10):1185-94. PubMed ID: 21992730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase receptor (uPAR) ligand based recombinant toxins for human cancer therapy.
    de Virgilio M; Silvestris F
    Curr Pharm Des; 2011; 17(19):1979-83. PubMed ID: 21711232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.